NCT03147612 2026-02-17
Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
1 trialsLeukemia, Myeloid, Accelerated Phase × N,N-dicyclohexyl-isoborneol-10-sulfonamide × 90 days × Clear all